Renal function and diuretic therapy in infants and children. Part II.
D000086:Acetazolamide / Q000009:adverse effects / Q000627:therapeutic use; D000450:Aldosterone / Q000378:metabolism; D001581:Benzothiadiazines; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D004232:Diuretics / Q000627:therapeutic use*; D004234:Diuretics, Osmotic / Q000009:adverse effects / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D005665:Furosemide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007668:Kidney / Q000187:drug effects*; D007678:Kidney Glomerulus / Q000187:drug effects; D007684:Kidney Tubules / Q000187:drug effects; D009941:Organomercury Compounds / Q000009:adverse effects / Q000627:therapeutic use; D010372:Pediatrics; D011188:Potassium / Q000378:metabolism; D011247:Pregnancy; D012964:Sodium / Q000378:metabolism; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use; D014223:Triamterene / Q000009:adverse effects / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D001581:Benzothiadiazines; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics; D004234:Diuretics, Osmotic; D009941:Organomercury Compounds; D049993:Sodium Chloride Symporter Inhibitors; D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D012964:Sodium; D004976:Ethacrynic Acid; D000086:Acetazolamide; D011188:Potassium; D014223:Triamterene